1.an oral drug that acts as an ACE inhibitor.
1.The results showed mice treated with lisinopril before the injection did not develop the paralysis related to MS.
结果显示注射化学物质前用赖诺普利治疗的大鼠不会出现由多发性硬化症引起的瘫痪。
2.There was metformin HCl and glipizide for his diabetes; lisinopril for his blood pressure; and Viagra.
药单包括治疗糖尿病的盐酸二甲双胍和格列吡嗪、治疗高血压的赖诺普利、伟哥。
3.Blood pressure- and pulse pressure-lowering effects, trough: peak ratio and smoothness index of telmisartan compared with lisinopril.
替米沙坦与赖诺普利降低血压和脉压疗效：谷峰比值和平滑指数的比较。
4.If future studies confirm these results, lisinopril may provide a less expensive treatment alternative for multiple sclerosis.
如果未来的研究证实了这个结果，赖诺普利可以为我们提供另外一种价格低廉的多发性硬化症治疗方案。
5.The first involves the use of the drugs lisinopril, carvedilol, spironolactone, and losartan to enhance reverse remodelling.
第一个阶段包括药物赖诺普利，卡维地洛、螺内酯和洛沙坦的应用，以提高逆转重塑。
6.Conclusion Lisinopril and levoamlodipine in treatment of patients with hypertension are effective, and the adverse effects are fewer.
结论赖诺普利和左旋氨氯地平均具有明显的降压作用，且副作用少。
7.Chlorthalidone also reduced the incidence of new-onset HFPEF compared with lisinopril.
与赖诺普利相比，氯噻酮能减少HFPEF发生率。
8.Objective To investigate the effect of Fluvastain Sodium and Lisinopril on insulin resistance in type 2 diabetes mellitus(T2DM).
目的观察氟伐他汀及赖诺普利对2型糖尿病患者血脂、血压、空腹血糖、空腹胰岛素及胰岛素敏感性指数的影响。
9.Bioequivalence assessment of two lisinopril tablets in healthy volunteers
赖诺普利片在健康志愿者体内的生物等效性评价
10.Clinical trial design of compound lisinopril in treatment essential hypertension in Chinese patients
复方赖诺普利片治疗中国人群原发性高血压的临床试验设计